Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Cholanamide components for organic alloys; expanding the scope of nanoporous steroidal ureas

Leana Travaglini ab, Lydia N. Bridgland a and Anthony P. Davis *a
aSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS1 1TS, UK. E-mail: Anthony.Davis@bristol.ac.uk; Fax: +44-(0)117 9298611; Tel: +44-(0)117 9546334
bDepartment of Chemistry, “Sapienza” University of Rome, Ple. Aldo Moro 5, 00185, Rome, Italy

Received 17th February 2014 , Accepted 24th March 2014

First published on 25th March 2014


Abstract

Amide-linked side-chains can substitute for esters in crystalline nanoporous steroidal ureas (NSPUs). This efficient conjugation method increases the versatility of NPSUs, and should aid the inclusion of complex functional units in the crystal channels.


The rational design of porous solids is a major goal of crystal engineering.1 Crystalline systems which contain pores ranging from ∼0.5 to 2.0 nm are of particular interest, as this can allow penetration by a range of molecular guests. Such absorptive properties can lead to applications including gas storage,2 catalysis3 or molecular separations.4 There is thus much interest in the preparation of nanoporous crystals, especially where properties can be tailored for different purposes. Success has been achieved using various approaches, including metal–organic frameworks, preformed molecular cavities (“intrinsically porous” molecules5) and covalent organic frameworks.1e,2a,f,6 However, the creation of pores through the crystallisation of non-macrocyclic organic molecules (“extrinsic porosity”) remains a particular challenge. There are especially few examples where pore size and material properties can be tuned,7 and even in those cases the possible variations within the packing motif are relatively narrow.

We have recently described a family of extrinsically porous crystals, the “nanoporous steroidal ureas” (NPSUs), which provides exceptional scope for variation.8 The crystals are formed from esters of substituted cholanoic acids, and the variations are possible (in part) because the ester group can be changed without affecting the packing (see below). Herein we report that the corresponding cholanamides may also be incorporated in NPSU crystals. This discovery expands the range of potential NPSUs, with particular relevance to the inclusion of complex functional units in the crystal pores.

An overview of the NPSU crystal family is given in Fig. 1. The molecules which form the crystals are represented by the general formula 1 (Fig. 1a) and are accessible in as little as 5 steps from cholic acid 2.9 The crystal structure of prototype 1a8a is shown in Fig. 1b, viewed down the c axis. The packing involves the formation of helices with hexagonal symmetry (space group = P61) surrounding solvent-filled channels. The terminal units (NHPh and OMe in this case) lie at the surface of these channels, largely constituting the walls. The channels are unusually wide (∼1.6 nm average diameter for 1a), so there is room for these groups to expand without disturbing the P61 crystal packing. Accordingly, groups R1 and R2 can be varied to give a range of isostructural crystals with different channel diameters and surface characteristics.8b,e Moreover, because their structures are so similar, different variants can co-crystallise in continuously variable ratios to form “organic alloys” (Fig. 1c).8c,d This facilitates tuning, and also allows very large units to be placed in the channels (through conjugation with the steroid then “doping” in a matrix of simpler “host” NPSU molecules). Studies on 1a have confirmed that it possesses permanent porosity (as indicated by evacuation and gas adsorption), and that it can take up a range of organic molecules including the C30 hydrocarbon squalene.8e


image file: c4cc01256a-f1.tif
Fig. 1 The NPSU crystal family. (a) General structure of NPSU monomers. (b) NPSU 1a in the crystal, viewed down the c axis. Terminal groups R1 (NHPh) and OR2 (OMe) are coloured gold and magenta respectively. To show the positioning of the individual molecules, two are highlighted (green and blue) with terminal groups in space filling mode. (c) Schematic depictions of channels in crystals, showing the helical arrangements of R1 and R2. Left: a solid solution with two types of R2. Right: placing a bulky R2 in the channel through low-level doping.

Although new NPSUs may be created by changing both R1 and R2, the latter has practical advantages. The methyl ester 1a is especially easy to synthesise,9 and modifying the methoxy group requires just hydrolysis and re-esterification. However while this process is often straightforward, esterification can be problematic especially if the alcohol is complex, hindered and/or hydrophilic. Amide formation is a highly reliable method of conjugation, and many groups of interest (e.g. peptides) are available as amines. Thus incorporation of cholanamides 3 would enhance the potential of NPSUs as functional materials. We therefore decided to establish whether the NPSU motif could be extended to cholanamides, at least for simple test cases.

The ability of amides 3 to participate in NPSU structures could be compromised by steric hindrance in the case of tertiary amides, or by the potential for new NH⋯X hydrogen bonds in the case of secondary amides. We chose to study examples of both types, the secondary amides 3a,b and the tertiary amides 3c,d. Amides 3a–d were prepared from tris-urea 1a by ester hydrolysis followed by coupling to methylamine, benzylamine, N-methylbenzylamine and dimethylamine using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) as condensing agent.

Attempts were made to crystallise 3a–d using our standard method for NPSUs, i.e. dissolving in acetone or methyl acetate, adding water, and allowing the organic solvent to evaporate. Unfortunately these trials were unsuccessful, yielding only white amorphous solids. Attempted crystallisations from other solvents (e.g. methanol, ethanol) produced similar results.

image file: c4cc01256a-u1.tif

While amides 3a–d might not crystallise as pure compounds, this did not preclude their incorporation in NPSUs. Given that NPSUs can form alloys,8c it seemed likely that crystals of an ester such as 1a might accept the amides as substitutes or dopants. Accordingly, we prepared mixtures of 3a–d with ester 1a in the ratios 1a[thin space (1/6-em)]:[thin space (1/6-em)]3 = 1[thin space (1/6-em)]:[thin space (1/6-em)]1, 2[thin space (1/6-em)]:[thin space (1/6-em)]1, and 5[thin space (1/6-em)]:[thin space (1/6-em)]1, dissolved in acetone, and subjected them to the standard NPSU crystallisation method (see above). All the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 mixtures failed to give crystals, yielding only amorphous solids. The same was true of the 2[thin space (1/6-em)]:[thin space (1/6-em)]1 mixtures incorporating secondary amides 3a and 3b. However, the mixtures 1a[thin space (1/6-em)]:[thin space (1/6-em)]3c,d = 2[thin space (1/6-em)]:[thin space (1/6-em)]1, and all 5[thin space (1/6-em)]:[thin space (1/6-em)]1 mixtures, gave needle-like crystals similar in appearance to those given by 1a (see Table 1). The collected crystals were all analyzed by 1H NMR spectroscopy to give the bulk compositions shown in Table 1, while the presence of both the components within individual crystals was confirmed by ESI-MS on single crystals. Attempts were made to detect the amide components in the 1a·3b–d mixtures using single crystal X-ray diffraction (SCXRD).10 However, while the data yielded evidence of the second components, it was not possible to model the amide substituents. The crystallography did provide confirmation that the crystals were indeed NPSUs, with the P61 packing and cell parameters listed in Table 1.

Table 1 Solid solutions formed by steroidal ureas 3 and 1a
Components Initial ratio Ratio in crystals (bulk)a Crystallographic unit cell detailsb
a,b [Å] c [Å] V [Å]3
a Determined by 1H NMR integration. b Standard deviations are given in parentheses. c Not determined.
1a, 3a 5[thin space (1/6-em)]:[thin space (1/6-em)]1 83[thin space (1/6-em)]:[thin space (1/6-em)]17
1a, 3b 5[thin space (1/6-em)]:[thin space (1/6-em)]1 76[thin space (1/6-em)]:[thin space (1/6-em)]24 29.0457(8) 11.4742(3) 8383.3(4)
1a, 3c 2[thin space (1/6-em)]:[thin space (1/6-em)]1 83[thin space (1/6-em)]:[thin space (1/6-em)]17 29.0994(4) 11.4992(3) 8432.7(3)
1a, 3c 5[thin space (1/6-em)]:[thin space (1/6-em)]1 91[thin space (1/6-em)]:[thin space (1/6-em)]9 29.0759(4) 11.4900(3) 8441.4(3)
1a, 3d 2[thin space (1/6-em)]:[thin space (1/6-em)]1 70[thin space (1/6-em)]:[thin space (1/6-em)]30 29.0240(7) 11.4753(3) 8371.6(4)
1a, 3d 5[thin space (1/6-em)]:[thin space (1/6-em)]1 83[thin space (1/6-em)]:[thin space (1/6-em)]17 29.1007(3) 11.4979(2) 8432.5(2)


Although we cannot be certain that the distribution of 1a and 3 is random within the crystals, these results point clearly to co-crystallisation and, most probably, the formation of solid solutions (organic alloys). In particular, the ESI-MS spectra on single crystals show that 1a and 3 occur together, while the inability of 3 to crystallise alone suggests that all-amide domains are unlikely. It is encouraging to find that all the amides were incorporated, but interesting to note the difference between the secondary and tertiary amides. In the former case, alloy formation was only possible for the most dilute mixture (1a[thin space (1/6-em)]:[thin space (1/6-em)]3a,b = 5[thin space (1/6-em)]:[thin space (1/6-em)]1). However, when it did occur incorporation was efficient, the ratio in the crystals being similar to that in solution. For the tertiary amides incorporation was possible at higher starting concentrations, but was slightly less efficient (especially in the case of 3c).

In conclusion, we have found that the cholanoate NPSUs 1, already capable of variation and alloy formation, can be further modified by inclusion of cholanamides 3. If this discovery can be generalised it opens the way to a range of new materials in which complex functional units are positioned in the channels of nanoporous crystals.

We thank the “Sapienza” University of Rome for financial support to L. T. L. B. is a member of the Bristol Centre for Functional Nanomaterials, an EPSRC-funded Doctoral Training Centre.

Notes and references

  1. (a) D. Bradshaw, J. B. Claridge, E. J. Cussen, T. J. Prior and J. Rosseinsky, Acc. Chem. Res., 2005, 38, 273 CrossRef CAS PubMed; (b) M. D. Hollingsworth, Science, 2002, 295, 2410 CAS; (c) G. Ferey, C. Mellot-Draznieks, C. Serre and F. Millange, Acc. Chem. Res., 2005, 38, 217 CrossRef CAS PubMed; (d) S. Kitagawa, R. Kitaura and S. Noro, Angew. Chem., Int. Ed., 2004, 43, 2334 CrossRef CAS PubMed; (e) N. B. McKeown, J. Mater. Chem., 2010, 20, 10588 RSC; (f) M. K. Zaworogto, Angew. Chem., Int. Ed., 2000, 39, 3052 CrossRef; (g) P. J. Langley and J. Hulliger, Chem. Soc. Rev., 1999, 28, 279 RSC.
  2. (a) H. Furukawa, K. E. Cordova, M. O'Keeffe and O. M. Yaghi, Science, 2013, 341, 974 CrossRef CAS PubMed; (b) R. E. Morris and P. S. Wheatley, Angew. Chem., Int. Ed., 2008, 47, 4966 CrossRef CAS PubMed; (c) S. Ma and H. C. Zhou, Chem. Commun., 2010, 46, 44 RSC; (d) M. E. Davis, Nature, 2002, 417, 813 CrossRef CAS PubMed; (e) A. Comotti, S. Bracco, G. Distefano and P. Sozzani, Chem. Commun., 2009, 284 RSC; (f) H. Kim, Y. Kim, M. Yoon, S. Lim, S. M. Park, G. Seo and K. Kim, J. Am. Chem. Soc., 2010, 132, 12200 CrossRef CAS PubMed; (g) J. L. C. Rowsell and O. M. Yaghi, Angew. Chem., Int. Ed., 2005, 44, 4670 CrossRef CAS PubMed.
  3. (a) K. Ikemoto, Y. Inokuma and M. Fujita, Angew. Chem., Int. Ed., 2010, 49, 5750 CrossRef CAS PubMed; (b) J. Yang, M. B. Dewal and L. S. Shimizu, J. Am. Chem. Soc., 2006, 128, 8122 CrossRef CAS PubMed; (c) K. Endo, T. Koike, T. Sawaki, O. Hayashida, H. Masuda and Y. Aoyama, J. Am. Chem. Soc., 1997, 119, 4117 CrossRef CAS; (d) J. Y. Lee, O. K. Farha, J. Roberts, K. A. Scheidt, S. T. Nguyen and J. T. Hupp, Chem. Soc. Rev., 2009, 38, 1450 RSC; (e) S. H. Cho, B. Ma, S. B. T. Nguyen, J. T. Hupp and T. E. Albrecht-Schmitt, Chem. Commun., 2006, 2563 RSC.
  4. (a) E. D. Bloch, W. L. Queen, R. Krishna, J. M. Zadrozny, C. M. Brown and J. R. Long, Science, 2012, 335, 1606 CrossRef CAS PubMed; (b) R. V. Afonso, J. Durao, A. Mendes, A. M. Damas and L. Gales, Angew. Chem., Int. Ed., 2010, 49, 3034 CrossRef CAS PubMed; (c) H. Oh, I. Savchenko, A. Mavrandonakis, T. Heine and M. Hirscher, ACS Nano, 2014, 8, 761 CrossRef CAS PubMed; (d) D. Bradshaw, T. J. Prior, E. J. Cussen, J. B. Claridge and M. J. Rosseinsky, J. Am. Chem. Soc., 2004, 126, 6106 CrossRef CAS PubMed; (e) R. Vaidhyanathan, D. Bradshaw, J. N. Rebilly, J. P. Barrio, J. A. Gould, N. G. Berry and M. J. Rosseinsky, Angew. Chem., Int. Ed., 2006, 45, 6495 CrossRef CAS PubMed.
  5. J. R. Holst, A. Trewin and A. I. Cooper, Nat. Chem., 2010, 2, 915 CrossRef CAS PubMed.
  6. (a) K. E. Maly, J. Mater. Chem., 2009, 19, 1781 RSC; (b) R. Afonso, A. Mendes and L. Gales, J. Mater. Chem., 2012, 22, 1709 RSC; (c) J. R. Long and O. M. Yaghi, Chem. Soc. Rev., 2009, 38, 1213 RSC; (d) M. L. Foo, R. Matsuda and S. Kitagawa, Chem. Mater., 2014, 26, 310 CrossRef CAS; (e) S. M. Cohen, Chem. Sci., 2010, 1, 32 RSC; (f) K. L. Mulfort and J. T. Hupp, J. Am. Chem. Soc., 2007, 129, 9604 CrossRef CAS PubMed; (g) P. Dechambenoit, S. Ferlay, N. Kyritsakas and M. W. Hosseini, Chem. Commun., 2009, 1559 RSC; (h) T. Fukushima, S. Horike, Y. Inubushi, K. Nakagawa, Y. Kubota, M. Takata and S. Kitagawa, Angew. Chem., Int. Ed., 2010, 49, 4820 CrossRef CAS PubMed.
  7. See for example: (a) C. H. Gorbitz, Chem. – Eur. J., 2001, 7, 5153 CrossRef CAS; (b) C. H. Gorbitz, Chem. – Eur. J., 2007, 13, 1022 CrossRef PubMed; (c) D. V. Soldatov, I. L. Moudrakovski and J. A. Ripmeester, Angew. Chem., Int. Ed., 2004, 43, 6308 CrossRef CAS PubMed; (d) D. V. Soldatov, I. L. Moudrakovski, E. V. Grachev and J. A. Ripmeester, J. Am. Chem. Soc., 2006, 128, 6737 CrossRef CAS PubMed.
  8. (a) A. L. Sisson, V. del Amo Sanchez, G. Magro, A. M. E. Griffin, S. Shah, J. P. H. Charmant and A. P. Davis, Angew. Chem., Int. Ed., 2005, 44, 6878 CrossRef CAS PubMed; (b) R. Natarajan, J. P. H. Charmant, A. G. Orpen and A. P. Davis, Angew. Chem., Int. Ed., 2010, 49, 5125 CrossRef CAS PubMed; (c) R. Natarajan, G. Magro, L. N. Bridgland, A. Sirikulkajorn, S. Narayanan, L. E. Ryan, M. F. Haddow, A. G. Orpen, J. P. H. Charmant, A. Hudson and A. P. Davis, Angew. Chem., Int. Ed., 2011, 50, 11386 CrossRef CAS PubMed; (d) M. Mastalertz, Angew. Chem., Int. Ed., 2012, 51, 584 CrossRef PubMed; (e) R. Natarajan, L. Bridgland, A. Sirikulkajorn, J.-H. Lee, M. F. Haddow, G. Magro, B. Ali, S. Narayanan, P. Strickland, J. P. H. Charmant, A. G. Orpen, N. B. McKeown, C. G. Bezzu and A. P. Davis, J. Am. Chem. Soc., 2013, 135, 16912 CrossRef CAS PubMed.
  9. V. del Amo, K. Bhattarai, M. Nissinen, K. Rissanen, M. N. Perez-Payan and A. P. Davis, Synlett, 2005, 1319 CAS.
  10. The combination 1a·3a was not examined, in the expectation that the two components would be indistinguishable.

Footnote

Electronic supplementary information (ESI) available: Details of synthetic procedures, description of crystallisation and crystal analyses. See DOI: 10.1039/c4cc01256a

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.